Mark Tuthill - Concepedia

Author

Mark Tuthill

Also Known As

Anne S Rigg, M H Tuthill, M Tuthill, M. H. Tuthill, M. Tuthill, Mark H Tuthill, Mark H. Tuthill, Mark Tuthill, Samra Turajlic, Swapna Thummala

Publications

586

Citations

H-Index

Concepts

All Affiliations

Imperial College London University of Oxford Oxford University Hospitals NHS Trust Charing Cross Hospital Hammersmith Hospital

About

Mark Tuthill is an author at Imperial College London specializing in medicine, clinical specialties, and patient safety.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	232
2	Cell Biology	1	1	74
3	Immunology	1	1	74
4	Obstetrics	1	1	81
5	Pathology	1	1	67

Mark Tuthill

Publications

439

Citations

H-Index

Page 1

	Year	Citations
Brain metastases in gestational trophoblast neoplasia: An update on incidence, management and outcome Philip Savage, Inga K. Kelpanides, Mark Tuthill, Gynecologic Oncology Neuro-oncologyBrain MetastasesGynecologyGestational Trophoblast NeoplasiaMedicine	2015	81
TRAIL-R2-specific antibodies and recombinant TRAIL can synergise to kill cancer cells Mark Tuthill, Antonella Montinaro, Julia Zinngrebe, Oncogene ImmunologyImmune Checkpoint InhibitorTrail-r2-specific AntibodiesAntibody EngineeringTumor Targeting	2014	74
Peritoneal disease in breast cancer: A specific entity with an extremely poor prognosis Mark Tuthill, Robert Pell, Rosa Guiliani, European Journal of Cancer Surgical OncologyBreast OncologyPeritoneal DiseaseMedicinePathology	2009	67
COVID-19: Third dose booster vaccine effectiveness against breakthrough coronavirus infection, hospitalisations and death in patients with cancer: A population-based study Lennard Y. W. Lee, Maria C. Ionescu, Thomas Starkey, European Journal of Cancer	2022	63
The cost of a QALY R. Kirkdale, Jonathan Krell, Ciara O’Hanlon Brown, QJM	2010	37
Safety, cost-effectiveness and feasibility of daycase paracentesis in the management of malignant ascites with a focus on ovarian cancer V Harding, Elisabetta Fenu, Hanine Medani, British Journal of Cancer	2012	34
DUSP16 is an epigenetically regulated determinant of JNK signalling in Burkitt's lymphoma S Lee, Nelofer Syed, Joe Taylor, British Journal of Cancer	2010	33
Association of SARS-CoV-2 Spike Protein Antibody Vaccine Response With Infection Severity in Patients With Cancer Lennard Y. W. Lee, Michaël Tilby, Thomas Starkey, JAMA Oncology	2022	29
Digital Pathology Transformation in a Supraregional Germ Cell Tumour Network Richard Colling, Andrew Protheroe, Mark Sullivan, Diagnostics	2021	11
Changing Practice Evaluation—Stage 1 Seminoma: Outcomes With Adjuvant Treatment Versus Surveillance: Risk Factors for Recurrence and Optimizing Follow-up Protocols—Experience From a Supraregional Center Helen E.J. Tyrrell, David N. Church, Johnson Joseph, Clinical Genitourinary Cancer Clinical EffectivenessPractice Evaluation—stage 1Patient SafetyClinical SpecialtiesOutcomes Research	2017	10

Page 1